| mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
8e-07 |
| mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
| mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
| mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
| mRNA |
AZD4547 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
| mRNA |
L-685458 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.0007 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0008 |